| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenue From Operations | 20,275.17 | 20,812.14 | 15,585.98 | 14,116.05 |
| Sale of Products | 19,843.53 | 20,394.63 | 15,518.50 | 13,988.40 |
| Sale of Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Fixed Assets | 27,457.53 | 28,429.93 | 23,154.45 | 22,183.29 |
| Property, Plant and Equipments | 10,192.32 | 10,390.38 | 10,371.38 | 10,234.99 |
| Right-of-Use Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 13,019.06 | 14,029.74 | 12,293.78 | 11,317.99 |
| Market Cap (Rs in Crs) | 3,86,268.94 | |
|---|---|---|
| P/E | 122.61 | |
| Book Value (Rs) | 98.33 | |
| Div (%) | 1350 | |
| Market Lot | 1 | |
| EPS (TTM) | 13.13 | |
|---|---|---|
| Price/Book | 16.37 | |
| Div Yield.(%) | 0.84 | |
| Face value (RS) | 1 | |
| Deliverables (%) | 63.8 | |
| Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
|---|---|---|---|---|---|
| Divis Laborator... | 1,48,381.01 | 5,589.40 | 5,567.60 | 0.39 | 6,448.75 - 3,350.05 |
| Cipla Ltd | 1,17,802.75 | 1,458.65 | 1,461.85 | -0.22 | 1,702.00 - 1,317.60 |
| Torrent Pharmac... | 1,03,969.15 | 3,072.10 | 3,058.65 | 0.44 | 3,589.95 - 2,488.00 |
| Mankind Pharma ... | 95,530.50 | 2,315.45 | 2,274.30 | 1.81 | 3,050.00 - 1,910.10 |
| Dr Reddys Labor... | 94,525.83 | 1,132.80 | 1,138.80 | -0.53 | 1,420.20 - 1,104.55 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
| Category | No. of Shares | Percentage |
|---|---|---|
| Total Foreign | 43,98,34,762 | 18.33 |
| Total Institutions | 44,50,47,053 | 18.55 |
| Total Govt Holding | 24,052 | 0.00 |
| Total Non Promoter Corporate Holding | 5,02,96,454 | 2.10 |
| Total Promoters | 1,30,71,34,535 | 54.48 |
| Total Public & others | 156998114 | 6.55 |
| Total | 2,39,93,34,970 | 100 |
